Do ATP and NO interact in the CNS?

Progress in Neurobiology

Volumn 84, Issue 1, 2008, Pages 40-56

  Florenzano, F ^a   Viscomi, M T ^a   Amadio, S ^a   D'Ambrosi, N ^a   Volonte C ^a,b   Molinari, M ^a  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b CNR   (Italy)

Author keywords

Brain injury; Neuron glia interactions; Nitric oxide synthase; Purinergic receptor

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PURINE P2 RECEPTOR;

AUDITORY SYSTEM; BRAIN INJURY; BRAIN ISCHEMIA; CALCIUM TRANSPORT; CELL DAMAGE; CELL FUNCTION; CELL INTERACTION; CENTRAL NERVOUS SYSTEM; GASTROINTESTINAL TRACT; HUMAN; INFLAMMATION; MEDICAL INFORMATION; NERVE FIBER TRANSECTION; NEUROPROTECTION; NEUROTOXICITY; NITRERGIC NERVE; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ADENOSINE TRIPHOSPHATE; ANIMALS; CELL COMMUNICATION; CENTRAL NERVOUS SYSTEM; HUMANS; NEUROGLIA; NEURONS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION;

EID: 37149022084     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2007.10.004     Document Type: Review

References (220)

1. Ahern G.P., Klyachko V.A., and Jackson M.B. cGMP and S-nitrosylation: two routes for modulation of neuronal excitability by NO. Trends Neurosci. 25 (2002) 510-517
2. Aktan F. iNOS-mediated nitric oxide production and its regulation. Life Sci. 75 (2004) 639-653
3. Alderton W.K., Cooper C.E., and Knowles R.G. Nitric oxide synthases: structure, function and inhibition. Biochem. J. 357 (2001) 593-615
4. Amadio S., D'Ambrosi N., Cavaliere F., Murra B., Sancesario G., Bernardi G., Burnstock G., and Volonté C. P2 receptor modulation and cytotoxic function in cultured CNS neurons. Neuropharmacology 42 (2002) 489-501
5. Andrew P.J., and Mayer B. Enzymatic function of nitric oxide synthases. Cardiovasc. Res. 43 (1999) 521-531
6. Anwyl R. Induction and expression mechanisms of postsynaptic NMDA receptor-independent homosynaptic long-term depression. Prog. Neurobiol. 78 (2006) 17-37
7. Arundine M., and Tymianski M. Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity. Cell Calcium 34 (2003) 325-337
8. Atkinson L., Batten T.F., and Deuchars J. P2X(2) receptor immunoreactivity in the dorsal vagal complex and area postrema of the rat. Neuroscience 99 (2000) 683-696
9. Atkinson L., Shigetomi E., Kato F., and Deuchars J. Differential increases in P2X receptor levels in rat vagal efferent neurones following a vagal nerve section. Brain Res. 977 (2003) 112-118
10. Bailey M.A., Turner C.M., Hus-Citharel A., Marchetti J., Imbert-Teboul M., Milner P., Burnstock G., and Unwin R.J. P2Y receptors present in the native and isolated rat glomerulus. Nephron Physiol. 96 (2004) 79-90
11. Bal-Price A., Moneer Z., and Brown G.C. Nitric oxide induces rapid, calcium-dependent release of vesicular glutamate and ATP from cultured rat astrocytes. Glia 40 (2002) 312-323
12. 2+ by activation of P2 receptors in submucosal neurons in short-term cultures. Eur. J. Pharmacol. 409 (2000) 243-257
13. Belai A., and Burnstock G. Evidence for coexistence of ATP and nitric oxide in non-adrenergic, non-cholinergic (NANC) inhibitory neurones in the rat ileum, colon and anococcygeus muscle. Cell Tissue Res 278 (1994) 197-200
14. Benko R., Undi S., Wolf M., Magyar K., Tovolgyi Z., Rumbus Z., and Bartho L. P(2) purinoceptors account for the non-nitrergic NANC relaxation in the rat ileum. Naunyn Schmiedebergs Arch. Pharmacol. 373 (2006) 319-324
15. Berridge M.J., Lipp P., and Bootman M.D. The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell Biol. 1 (2000) 11-21
16. Bianco F., Fumagalli M., Pravettoni E., D'Ambrosi N., Volonte C., Matteoli M., Abbracchio M.P., and Verderio C. Pathophysiological roles of extracellular nucleotides in glial cells: differential expression of purinergic receptors in resting and activated microglia. Brain Res. Brain Res. Rev. 48 (2005) 144-156
17. Boeckxstaens G.E., Pelckmans P.A., Bult H., De Man J.G., Herman A.G., and Van Maercke Y.M. Evidence for nitric oxide as mediator of non-adrenergic non-cholinergic relaxations induced by ATP and GABA in the canine gut. Br. J. Pharmacol. 102 (1991) 434-438
18. Boehm S. ATP stimulates sympathetic transmitter release via presynaptic P2X purinoceptors. J. Neurosci. 19 (1999) 737-746
19. Boeynaems J.M., Pirotton S., Van Coevorden A., Raspe E., Demolle D., and Erneux C. P2-purinergic receptors in vascular endothelial cells: from concept to reality. J.Receptor Res. 8 (1988) 121-132
20. Borjesson L., Nordgren S., and Delbro D.S. DMPP causes relaxation of rat distal colon by a purinergic and a nitrergic mechanism. Eur. J. Pharmacol. 334 (1997) 223-231
21. Boucsein C., Zacharias R., Farber K., Pavlovic S., Hanisch U.K., and Kettenmann H. Purinergic receptors on microglial cells: functional expression in acute brain slices and modulation of microglial activation in vitro. Eur. J. Neurosci. 17 (2003) 2267-2276
22. Boue-Grabot E., Barajas-Lopez C., Chakfe Y., Blais D., Belanger D., Emerit M.B., and Seguela P. Intracellular cross talk and physical interaction between two classes of neurotransmitter-gated channels. J. Neurosci. 23 (2003) 1246-1253
23. Boue-Grabot E., Toulme E., Emerit M.B., and Garret M. Subunit-specific coupling between gamma-aminobutyric acid type A and P2X2 receptor channels. J. Biol. Chem. 279 (2004) 52517-52525
24. Boullerne A.I., and Benjamins J.A. Nitric oxide synthase expression and nitric oxide toxicity in oligodendrocytes. Antioxid. Redox Signal. 8 (2006) 967-980
25. Bradbury E.J., Burnstock G., and McMahon S.B. The expression of P2X3 purinoreceptors in sensory neurons: effects of axotomy and glial-derived neurotrophic factor. Mol. Cell. Neurosci. 12 (1998) 256-268
26. Brautigam V.M., Frasier C., Nikodemova M., and Watters J.J. Purinergic receptor modulation of BV-2 microglial cell activity: potential involvement of p38 MAP kinase and CREB. J. Neuroimmunol. 166 (2005) 113-125
27. Bredt D.S., and Snyder S.H. Nitric oxide, a novel neuronal messenger. Neuron 8 (1992) 3-11
28. Bredt D.S., and Snyder S.H. Nitric oxide: a physiologic messenger molecule. Annu. Rev. Biochem. 63 (1994) 175-195
29. Brown G.C., and Bal-Price A. Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol. Neurobiol. 27 (2003) 325-355
30. Buffo A., Fronte M., Oestreicher A.B., and Rossi F. Degenerative phenomena and reactive modifications of the adult rat inferior olivary neurons following axotomy and disconnection from their targets. Neuroscience 85 (1998) 587-604
31. Burnstock G. Purinergic cotransmission. Brain Res. Bull. 50 (1999) 355-357
32. Burnstock G. Purinergic signalling in gut. Purinergic and Pyrimidinergic Signalling. II. Cardiovascular, Respiratory, Immune Metabolic and Gastrointestinal Tract Function (2001), Springer-Verlag, Berlin pp. 141-238
33. Burnstock G. Purinergic signaling and vascular cell proliferation and death. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 364-373
34. Burnstock G. Cotransmission. Curr. Opin. Pharmacol. 4 (2004) 47-52
35. Burnstock G. Historical review: ATP as a neurotransmitter. Trends Pharmacol. Sci. 27 (2006) 166-176
36. Burnstock G. Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol. Rev. 58 (2006) 58-86
37. Burnstock G. Purinergic signalling-an overview. Novartis Found. Symp. 276 (2006) 26-48
38. Burnstock G. Vessel tone and remodeling. Nat. Med. 12 (2006) 16-17
39. Burnstock G. Purine and pyrimidine receptors. Cell. Mol. Life Sci. (2007)
40. Butt A.M. Neurotransmitter-mediated calcium signalling in oligodendrocyte physiology and pathology. Glia 54 (2006) 666-675
41. Buvinic S., Briones R., and Huidobro-Toro J.P. P2Y(1) and P2Y(2) receptors are coupled to the NO/cGMP pathway to vasodilate the rat arterial mesenteric bed. Br. J. Pharmacol. 136 (2002) 847-856
42. 2-chemoreceptors: role in nitric oxide-mediated efferent inhibition. J. Neurosci. 26 (2006) 9482-9493
43. Carroll J., Raththagala M., Subasinghe W., Baguzis S., D'amico O.T., Root P., and Spence D. An altered oxidant defense system in red blood cells affects their ability to release nitric oxide-stimulating ATP. Mol. Biosyst. 2 (2006) 305-311
44. Castelucci P., Robbins H.L., Poole D.P., and Furness J.B. The distribution of purine P2X(2) receptors in the guinea-pig enteric nervous system. Histochem. Cell Biol. 117 (2002) 415-422
45. Cavaliere F., D'Ambrosi N., Ciotti M.T., Mancino G., Sancesario G., Bernardi G., and Volonté C. Glucose deprivation and chemical hypoxia: neuroprotection by P2 receptor antagonists. Neurochem. Int. 38 (2001) 189-197
46. Cavaliere F., D'Ambrosi N., Sancesario G., Bernardi G., and Volonté C. Hypoglycaemia-induced cell death: features of neuroprotection by the P2 receptor antagonist basilen blue. Neurochem. Int. 38 (2001) 199-207
47. Cavaliere F., Florenzano F., Amadio S., Fusco F.R., Viscomi M.T., D'Ambrosi N., Vacca F., Sancesario G., Bernardi G., Molinari M., and Volonté C. Up-regulation of P2X2, P2X4 receptor and ischemic cell death: prevention by P2 antagonists. Neuroscience 120 (2003) 85-98
48. Choi B.M., Pae H.O., Jang S.I., Kim Y.M., and Chung H.T. Nitric oxide as a pro-apoptotic as well as anti-apoptotic modulator. J. Biochem. Mol. Biol. 35 (2002) 116-126
49. Chung H.T., Pae H.O., Choi B.M., Billiar T.R., and Kim Y.M. Nitric oxide as a bioregulator of apoptosis. Biochem. Biophys. Res. Commun. 282 (2001) 1075-1079
50. Cizkova D., Lukacova N., Marsala M., and Marsala J. Neuropathic pain is associated with alterations of nitric oxide synthase immunoreactivity and catalytic activity in dorsal root ganglia and spinal dorsal horn. Brain Res. Bull. 58 (2002) 161-171
51. Cohen R.A., and Adachi T. Nitric-oxide-induced vasodilatation: regulation by physiologic S-glutathiolation and pathologic oxidation of the sarcoplasmic endoplasmic reticulum calcium ATPase. Trends Cardiovasc. Med. 16 (2006) 109-114
52. Contestabile A. Roles of NMDA receptor activity and nitric oxide production in brain development. Brain Res. Brain Res. Rev. 32 (2000) 476-509
53. Contestabile A., Monti B., Contestabile A., and Ciani E. Brain nitric oxide and its dual role in neurodegeneration/neuroprotection: understanding molecular mechanisms to devise drug approaches. Curr. Med. Chem. 10 (2003) 2147-2174
54. Cunha R.A., and Ribeiro J.A. ATP as a presynaptic modulator. Life Sci. 68 (2000) 119-137
55. D'Ambrosi N., Murra B., Vacca F., and Volonté C. Pathways of survival induced by NGF and extracellular ATP after growth factor deprivation. Prog. Brain Res. 146 (2004) 93-100
56. D'amico O.T., Root P., and Spence D.M. Fluorescence monitoring of ATP-stimulated, endothelium-derived nitric oxide production in channels of a poly(dimethylsiloxane)-based microfluidic device. Anal. Chem. 78 (2006) 3193-3197
57. Dawson T.M., and Dawson V.L. Nitric oxide synthase: role as a transmitter/mediator in the brain and endocrine system. Annu. Rev. Med. 47 (1996) 219-227
58. Dawson T.M., and Snyder S.H. Gases as biological messengers: nitric oxide and carbon monoxide in the brain. J. Neurosci. 14 (1994) 5147-5159
59. Dawson T.M., Dawson V.L., and Snyder S.H. A novel neuronal messenger molecule in brain: the free radical, nitric oxide. Ann. Neurol. 32 (1992) 297-311
60. De Luca A., Li C.G., and Rand M.J. Nitrergic and purinergic mechanisms and their interactions for relaxation of the rat internal anal sphincter. J. Auton. Pharmacol. 19 (1999) 29-37
61. Di Garbo A., Barbi M., Chillemi S., Alloisio S., and Nobile M. Calcium signalling in astrocytes and modulation of neural activity. Biosystems (2006)
62. Dienel G.A., and Hertz L. Astrocytic contributions to bioenergetics of cerebral ischemia. Glia 50 (2005) 362-388
63. Egan T.M., and Khakh B.S. Contribution of calcium ions to P2X channel responses. J. Neurosci. 24 (2004) 3413-3420
64. Egan T.M., Samways D.S., and Li Z. Biophysics of P2X receptors. Pflugers Arch. 452 (2006) 501-512
65. Erb L., Liao Z., Seye C.I., and Weisman G.A. P2 receptors: intracellular signaling. Pflugers Arch. 452 (2006) 552-562
66. Estevez A.G., and Jordan J. Nitric oxide and superoxide, a deadly cocktail. Ann. N. Y. Acad. Sci. 962 (2002) 207-211
67. Farber K., and Kettenmann H. Functional role of calcium signals for microglial function. Glia 54 (2006) 656-665
68. Farber K., and Kettenmann H. Purinergic signaling and microglia. Pflugers Arch. 452 (2006) 615-621
69. Farre R., Auli M., Lecea B., Martinez E., and Clave P. Pharmacologic characterization of intrinsic mechanisms controlling tone and relaxation of porcine lower esophageal sphincter. J. Pharmacol. Exp. Ther. 316 (2006) 1238-1248
70. Fields R.D., and Burnstock G. Purinergic signalling in neuron-glia interactions. Nat. Rev. Neurosci. 7 (2006) 423-436
71. Fields R.D., and Stevens B. ATP: an extracellular signaling molecule between neurons and glia. Trends Neurosci. 23 (2000) 625-633
72. Figueroa S., Oset-Gasque M.J., Arce C., Martinez-Honduvilla C.J., and Gonzalez M.P. Mitochondrial involvement in nitric oxide-induced cellular death in cortical neurons in culture. J. Neurosci. Res. 83 (2006) 441-449
73. Fleming I., and Busse R. Signal transduction of eNOS activation. Cardiovasc. Res. 43 (1999) 532-541
74. Florenzano F., Viscomi M.T., Cavaliere F., Volonte C., and Molinari M. Cerebellar lesion up-regulates P2X1 and P2X2 purinergic receptors in precerebellar nuclei. Neuroscience 115 (2002) 425-434
75. Florenzano F., Viscomi M.T., Cavaliere F., Volonte C., and Molinari M. The role of ionotropic purinergic receptors (P2X) in mediating plasticity responses in the central nervous system. Adv. Exp. Med. Biol. 557 (2006) 77-100
76. Florenzano F., Viscomi M.T., Mercaldo V., Longone P., Bernardi G., Bagni C., Molinari M., and Carrive P. P2X2R purinergic receptor subunit mRNA and protein are expressed by all hypothalamic hypocretin/orexin neurons. J. Comp. Neurol. 498 (2006) 58-67
77. Foster M.W., McMahon T.J., and Stamler J.S. S-nitrosylation in health and disease. Trends Mol. Med. 9 (2003) 160-168
78. Franke H., and Illes P. Involvement of P2 receptors in the growth and survival of neurons in the CNS. Pharmacol. Ther. 109 (2006) 297-324
79. Franke H., Krugel U., and Illes P. P2 receptor-mediated proliferative effects on astrocytes in vivo. Glia 28 (1999) 190-200
80. Franke H., Krugel U., Schmidt R., Grosche J., Reichenbach A., and Illes P. P2 receptor-types involved in astrogliosis in vivo. Br. J. Pharmacol. 134 (2001) 1180-1189
81. Franke H., Gunther A., Grosche J., Schmidt R., Rossner S., Reinhardt R., Faber-Zuschratter H., Schneider D., and Illes P. P2X7 receptor expression after ischemia in the cerebral cortex of rats. J. Neuropathol. Exp. Neurol. 63 (2004) 686-699
82. Franke H., Krugel U., and Illes P. P2 receptors and neuronal injury. Pflugers Arch. 452 (2006) 622-644
83. Garthwaite J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. 14 (1991) 60-67
84. Garthwaite J. Neural nitric oxide signalling. Trends Neurosci. 18 (1995) 51-52
85. Gendron F.P., Chalimoniuk M., Strosznajder J., Shen S., Gonzalez F.A., Weisman G.A., and Sun G.Y. P2X7 nucleotide receptor activation enhances IFN gamma-induced type II nitric oxide synthase activity in BV-2 microglial cells. J. Neurochem. 87 (2003) 344-352
86. Gever J.R., Cockayne D.A., Dillon M.P., Burnstock G., and Ford A.P. Pharmacology of P2X channels. Pflugers Arch. 452 (2006) 513-537
87. Giaroni C., Knight G.E., Ruan H.Z., Glass R., Bardini M., Lecchini S., Frigo G., and Burnstock G. P2 receptors in the murine gastrointestinal tract. Neuropharmacology 43 (2002) 1313-1323
88. Giaroni C., Knight G.E., Zanetti E., Chiaravalli A.M., Lecchini S., Frigo G., and Burnstock G. Postnatal development of P2 receptors in the murine gastrointestinal tract. Neuropharmacology 50 (2006) 690-704
89. Gibson C.L., Coughlan T.C., and Murphy S.P. Glial nitric oxide and ischemia. Glia 50 (2005) 417-426
90. Girgin S.F., Sozmen E.Y., Ersoz B., and Mentes G. Link between monoamine oxidase and nitric oxide. Neurotoxicology 25 (2004) 91-99
91. Gu J.G., and MacDermott A.B. Activation of ATP P2X receptors elicits glutamate release from sensory neuron synapses. Nature 389 (1997) 749-753
92. Guix F.X., Uribesalgo I., Coma M., and Munoz F.J. The physiology and pathophysiology of nitric oxide in the brain. Prog. Neurobiol. 76 (2005) 126-152
93. Harukuni I., and Bhardwaj A. Mechanisms of brain injury after global cerebral ischemia. Neurol. Clin. 24 (2006) 1-21
94. Hassessian H., and Burnstock G. Interacting roles of nitric oxide and ATP in the pulmonary circulation of the rat. Br. J. Pharmacol. 114 (1995) 846-850
95. He M.L., Zemkova H., Koshimizu T.A., Tomic M., and Stojilkovic S.S. Intracellular calcium measurements as a method in studies on activity of purinergic P2X receptor channels. Am. J. Physiol.-Cell Physiol. 285 (2003) C467-C479
96. Hugel S., and Schlichter R. Presynaptic P2X receptors facilitate inhibitory GABAergic transmission between cultured rat spinal cord dorsal horn neurons. J. Neurosci. 20 (2000) 2121-2130
97. Iadecola C., and Ross M.E. Molecular pathology of cerebral ischemia: delayed gene expression and strategies for neuroprotection. Ann. N. Y. Acad. Sci. 835 (1997) 203-217
98. Ishiguchi T., Takahashi T., Itoh H., and Owyang C. Nitrergic and purinergic regulation of the rat pylorus. Am. J. Physiol.-Gastrointest. Liver Physiol. 279 (2000) G740-G747
99. James G., and Butt A.M. P2X and P2Y purinoreceptors mediate ATP-evoked calcium signalling in optic nerve glia in situ. Cell Calcium 30 (2001) 251-259
100. Juranyi Z., Sperlagh B., and Vizi E.S. Involvement of P2 purinoceptors and the nitric oxide pathway in [3H]purine outflow evoked by short-term hypoxia and hypoglycemia in rat hippocampal slices. Brain Res. 823 (1999) 183-190
101. Kanjhan R., Housley G.D., Burton L.D., Christie D.L., Kippenberger A., Thorne P.R., Luo L., and Ryan A.F. Distribution of the P2X2 receptor subunit of the ATP-gated ion channels in the rat central nervous system. J. Comp. Neurol. 407 (1999) 11-32
102. Karanjia R., Garcia-Hernandez L.M., Miranda-Morales M., Somani N., Espinosa-Luna R., Montano L.M., and Barajas-Lopez C. Cross-inhibitory interactions between GABAA and P2X channels in myenteric neurones. Eur. J. Neurosci. 23 (2006) 3259-3268
103. Kassa R.M., Bentivoglio M., and Mariotti R. Changes in the expression of P2X(1) and P2X(2) purinergic receptors in facial motoneurons after nerve lesions in rodents and correlation with motoneuron degeneration. Neurobiol. Dis. 25 (2007) 121-133
104. Keilhoff G., Fansa H., and Wolf G. Neuronal nitric oxide synthase is the dominant nitric oxide supplier for the survival of dorsal root ganglia after peripheral nerve axotomy. J. Chem. Neuroanat. 24 (2002) 181-187
105. Kelm M., Feelisch M., Spahr R., Piper H.M., Noack E., and Schrader J. Quantitative and kinetic characterization of nitric oxide and EDRF released from cultured endothelial cells. Biochem. Biophys. Res. Commun. 154 (1988) 236-244
106. Khakh B.S. Molecular physiology of P2X receptors and ATP signalling at synapses. Nat. Rev. Neurosci. 2 (2001) 165-174
107. Khakh B.S., and North R.A. P2X receptors as cell-surface ATP sensors in health and disease. Nature 442 (2006) 527-532
108. Khakh B.S., Zhou X., Sydes J., Galligan J.J., and Lester H.A. State-dependent cross-inhibition between transmitter-gated cation channels. Nature 406 (2000) 405-410
109. Khakh B.S., Fisher J.A., Nashmi R., Bowser D.N., and Lester H.A. An angstrom scale interaction between plasma membrane ATP-gated P2X2 and alpha4beta2 nicotinic channels measured with fluorescence resonance energy transfer and total internal reflection fluorescence microscopy. J. Neurosci. 25 (2005) 6911-6920
110. Kharlamov A., Jones S.C., and Kim D.K. Suramin reduces infarct volume in a model of focal brain ischemia in rats. Exp. Brain Res. 147 (2002) 353-359
111. Kimelberg H.K. Increased release of excitatory amino acids by the actions of ATP and peroxynitrite on volume-regulated anion channels (VRACs) in astrocytes. Neurochem. Int. 45 (2004) 511-519
112. Kirchner S.M., Bonan C.D., Battastini A.M., and Sarkis J.J. Effect of nitric oxide donors on extracellular ATP, ADP, and AMP catabolism in rat hippocampal synaptosomes. Brain Res. Bull. 55 (2001) 469-473
113. 2+ release from InsP3-sensitive internal stores in mammalian oligodendrocytes. J. Physiol. 483 Pt 1 (1995) 41-57
114. Kiss J.P. Role of nitric oxide in the regulation of monoaminergic neurotransmission. Brain Res. Bull. 52 (2000) 459-466
115. Kiss J.P., and Vizi E.S. Nitric oxide: a novel link between synaptic and nonsynaptic transmission. Trends Neurosci. 24 (2001) 211-215
116. Kittner H., Franke H., Fischer W., Schultheis N., Krugel U., and Illes P. Stimulation of P2Y1 receptors causes anxiolytic-like effects in the rat elevated plus-maze: implications for the involvement of P2Y1 receptor-mediated nitric oxide production. Neuropsychopharmacology 28 (2003) 435-444
117. Kittner H., Franke H., Harsch J.I., El Ashmawy I.M., Seidel B., Krugel U., and Illes P. Enhanced food intake after stimulation of hypothalamic P2Y1 receptors in rats: modulation of feeding behaviour by extracellular nucleotides. Eur. J. Neurosci. 24 (2006) 2049-2056
118. Koshimizu T.A., Van Goor F., Tomic M., Wong A.O., Tanoue A., Tsujimoto G., and Stojilkovic S.S. Characterization of calcium signaling by purinergic receptor-channels expressed in excitable cells. Mol. Pharmacol. 58 (2000) 936-945
119. Kristensson K., Aldskogius M., Peng Z.C., Olsson T., Aldskogius H., and Bentivoglio M. Co-induction of neuronal interferon-gamma and nitric oxide synthase in rat motor neurons after axotomy: a role in nerve repair or death?. J. Neurocytol. 23 (1994) 453-459
120. Krugel U., Kittner H., Franke H., and Illes P. Accelerated functional recovery after neuronal injury by P2 receptor blockade. Eur. J. Pharmacol. 420 (2001) R3-R4
121. Kucher B.M., and Neary J.T. Bi-functional effects of ATP/P2 receptor activation on tumor necrosis factor-alpha release in lipopolysaccharide-stimulated astrocytes. J. Neurochem. 92 (2005) 525-535
122. Kunapuli S.P., and Daniel J.L. P2 receptor subtypes in the cardiovascular system. Biochem. J. 336 Pt 3 (1998) 513-523
123. Lancaste Jr. J.R. A tutorial on the diffusibility and reactivity of free nitric oxide. Nitric Oxide 1 (1997) 18-30
124. Le Feuvre R.A., Brough D., Touzani O., and Rothwell N.J. Role of P2X7 receptors in ischemic and excitotoxic brain injury in vivo. J. Cereb. Blood Flow Metab. 23 (2003) 381-384
125. Leong S.K., Ruan R.S., and Zhang Z. A critical assessment of the neurodestructive and neuroprotective effects of nitric oxide. Ann. N. Y. Acad. Sci. 962 (2002) 161-181
126. Li H., and Poulos T.L. Structure-function studies on nitric oxide synthases. J. Inorg. Biochem. 99 (2005) 293-305
127. Li N., Sul J.Y., and Haydon P.G. A calcium-induced calcium influx factor, nitric oxide, modulates the refilling of calcium stores in astrocytes. J. Neurosci. 23 (2003) 10302-10310
128. Licinio J., Prolo P., McCann S.M., and Wong M.L. Brain iNOS: current understanding and clinical implications. Mol. Med. Today 5 (1999) 225-232
129. Lipton S.A. Neuronal protection and destruction by NO. Cell Death Differ. 6 (1999) 943-951
130. Lipton S.A., Choi Y.B., Takahashi H., Zhang D., Li W., Godzik A., and Bankston L.A. Cysteine regulation of protein function-as exemplified by NMDA-receptor modulation. Trends Neurosci. 25 (2002) 474-480
131. Liu J.S., John G.R., Sikora A., Lee S.C., and Brosnan C.F. Modulation of interleukin-1beta and tumor necrosis factor alpha signaling by P2 purinergic receptors in human fetal astrocytes. J. Neurosci. 20 (2000) 5292-5299
132. Loesch A. Perivascular nerves and vascular endothelium: recent advances. Histol. Histopathol. 17 (2002) 591-597
133. Mariotti R., and Bentivoglio M. Botulinum toxin induces nitric oxide synthase activity in motoneurons. Neurosci. Lett. 219 (1996) 25-28
134. Mariotti R., Peng Z.C., Kristensson K., and Bentivoglio M. Age-dependent induction of nitric oxide synthase activity in facial motoneurons after axotomy. Exp. Neurol. 145 (1997) 361-370
135. Matharu M.S., and Hollingsworth M. Purinoceptors mediating relaxation and spasm in the rat gastric fundus. Br. J. Pharmacol. 106 (1992) 395-403
136. Matsuda N.M., Feitosa Jr. R.L., Lemos M.C., De Oliveira R.B., and Ballejo G. In vitro and in vivo effects of nitric oxide synthase inhibitors and nitric oxide inactivators on the South American opossum ileocolonic junction. Neurogastroenterol. Motil. 10 (1998) 245-252
137. Matsuyama H., El Mahmoudy A., Shimizu Y., and Takewaki T. Nitrergic prejunctional inhibition of purinergic neuromuscular transmission in the hamster proximal colon. J. Neurophysiol. 89 (2003) 2346-2353
138. 2+ mobilization and functional responses in microglia: effects of low levels of ATP. J. Neurosci. Res. 81 (2005) 349-356
139. Melani A., Amadio S., Gianfriddo M., Vannucchi M.G., Volonte C., Bernardi G., Pedata F., and Sancesario G. P2X7 receptor modulation on microglial cells and reduction of brain infarct caused by middle cerebral artery occlusion in rat. J. Cereb. Blood Flow Metab. 26 (2006) 974-982
140. Mizuno O., Kobayashi S., Hirano K., Nishimura J., Kubo C., and Kanaide H. Stimulus-specific alteration of the relationship between cytosolic Ca(2+) transients and nitric oxide production in endothelial cells ex vivo. Br. J. Pharmacol. 130 (2000) 1140-1146
141. Moncada S. Adventures in vascular biology: a tale of two mediators. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 361 (2006) 735-759
142. Moncada S., and Bolanos J.P. Nitric oxide, cell bioenergetics and neurodegeneration. J. Neurochem. 97 (2006) 1676-1689
143. Moncada S., Radomski M.W., and Palmer R.M. Endothelium-derived relaxing factor Identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem. Pharmacol. 37 (1988) 2495-2501
144. Murakami K., Nakamura Y., and Yoneda Y. Potentiation by ATP of lipopolysaccharide-stimulated nitric oxide production in cultured astrocytes. Neuroscience 117 (2003) 37-42
145. Nakanishi S., Nakajima Y., Masu M., Ueda Y., Nakahara K., Watanabe D., Yamaguchi S., Kawabata S., and Okada M. Glutamate receptors: brain function and signal transduction. Brain Res. Brain Res. Rev. 26 (1998) 230-235
146. Nakatsuka T., and Gu J.G. P2X purinoceptors and sensory transmission. Pflugers Arch. 452 (2006) 598-607
147. Nakatsuka T., Mena N., Ling J., and Gu J.G. Depletion of substance P from rat primary sensory neurons by ATP, an implication of P2X receptor-mediated release of substance P. Neuroscience 107 (2001) 293-300
148. Narcisse L., Scemes E., Zhao Y., Lee S.C., and Brosnan C.F. The cytokine IL-1beta transiently enhances P2X7 receptor expression and function in human astrocytes. Glia 49 (2005) 245-258
149. Neary J.T., Kang Y., Shi Y.F., Tran M.D., and Wanner I.B. P2 receptor signalling, proliferation of astrocytes, and expression of molecules involved in cell-cell interactions. Novartis Found. Symp. 276 (2006) 131-143
150. Norenberg W., and Illes P. Neuronal P2X receptors: localisation and functional properties. Naunyn Schmiedebergs Arch. Pharmacol. 362 (2000) 324-339
151. North R.A. Molecular physiology of P2X receptors. Physiol. Rev. 82 (2002) 1013-1067
152. Novakovic S.D., Kassotakis L.C., Oglesby I.B., Smith J.A., Eglen R.M., Ford A.P., and Hunter J.C. Immunocytochemical localization of P2X3 purinoceptors in sensory neurons in naive rats and following neuropathic injury. Pain 80 (1999) 273-282
153. Ohkuma S., and Katsura M. Nitric oxide and peroxynitrite as factors to stimulate neurotransmitter release in the CNS. Prog. Neurobiol. 64 (2001) 97-108
154. Ohtani Y., Minami M., and Satoh M. Expression of inducible nitric oxide synthase mRNA and production of nitric oxide are induced by adenosine triphosphate in cultured rat microglia. Neurosci. Lett. 293 (2000) 72-74
155. Pacher P., Beckman J.S., and Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87 (2007) 315-424
156. Pampillo M., Scimonelli T., Bottino M.C., Duvilanski B.H., Rettori V., Seilicovich A., and Lasaga M. The effect of d-aspartate on luteinizing hormone-releasing hormone, alpha-melanocyte-stimulating hormone, GABA and dopamine release. Neuroreport 13 (2002) 2341-2344
157. Pankratov Y., Lalo U., Verkhratsky A., and North R.A. Vesicular release of ATP at central synapses. Pflugers Arch. 452 (2006) 589-597
158. Parvathenani L.K., Tertyshnikova S., Greco C.R., Roberts S.B., Robertson B., and Posmantur R. P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease. J. Biol. Chem. 278 (2003) 13309-13317
159. Poole D.P., Castelucci P., Robbins H.L., Chiocchetti R., and Furness J.B. The distribution of P2X3 purine receptor subunits in the guinea pig enteric nervous system. Auton. Neurosci. 101 (2002) 39-47
160. Prast H., and Philippu A. Nitric oxide as modulator of neuronal function. Prog. Neurobiol. 64 (2001) 51-68
161. Rathbone M.P., Middlemiss P.J., Gysbers J.W., Andrew C., Herman M.A., Reed J.K., Ciccarelli R., Di Iorio P., and Caciagli F. Trophic effects of purines in neurons and glial cells. Prog. Neurobiol. 59 (1999) 663-690
162. Rigas B. The use of nitric oxide-donating nonsteroidal anti-inflammatory drugs in the chemoprevention of colorectal neoplasia. Curr. Opin. Gastroenterol. 23 (2007) 55-59
163. Roberts J.A., Vial C., Digby H.R., Agboh K.C., Wen H., Atterbury-Thomas A., and Evans R.J. Molecular properties of P2X receptors. Pflugers Arch. 452 (2006) 486-500
164. Robertson S.J., Ennion S.J., Evans R.J., and Edwards F.A. Synaptic P2X receptors. Curr. Opin. Neurobiol. 11 (2001) 378-386
165. Ruan H.Z., and Burnstock G. The distribution of P2X5 purinergic receptors in the enteric nervous system of mouse. Cell Tissue Res. 319 (2005) 191-200
166. Ruan R.S., Leong S.K., and Yeoh K.H. Expression of NADPH-diaphorase activity in the facial motoneurons after compression of the facial nerve in the albino rat. Brain Res. 652 (1994) 350-352
167. Runden-Pran E., Tanso R., Haug F.M., Ottersen O.P., and Ring A. Neuroprotective effects of inhibiting N-methyl-d-aspartate receptors P2X receptors and the mitogen-activated protein kinase cascade: a quantitative analysis in organotypical hippocampal slice cultures subjected to oxygen and glucose deprivation. Neuroscience 136 (2005) 795-810
168. Ryu J.K., Kim J., Choi S.H., Oh Y.J., Lee Y.B., Kim S.U., and Jin B.K. ATP-induced in vivo neurotoxicity in the rat striatum via P2 receptors. Neuroreport 13 (2002) 1611-1615
169. Saha R.N., and Pahan K. Regulation of inducible nitric oxide synthase gene in glial cells. Antioxid. Redox Signal. 8 (2006) 929-947
170. Saha R.N., and Pahan K. Signals for the induction of nitric oxide synthase in astrocytes. Neurochem. Int. 49 (2006) 154-163
171. Saraiva R.M., and Hare J.M. Nitric oxide signaling in the cardiovascular system: implications for heart failure. Curr. Opin. Cardiol. 21 (2006) 221-228
172. Sarchielli P., Galli F., Floridi A., Floridi A., and Gallai V. Relevance of protein nitration in brain injury: a key pathophysiological mechanism in neurodegenerative, autoimmune, or inflammatory CNS diseases and stroke. Amino Acids 25 (2003) 427-436
173. Seidel B., Bigl M., Franke H., Kittner H., Kiess W., Illes P., and Krugel U. Expression of purinergic receptors in the hypothalamus of the rat is modified by reduced food availability. Brain Res. 1089 (2006) 143-152
174. 2+ response in inner hair cells of the guinea pig cochlea. Neurosci. Lett. 337 (2003) 135-138
175. 2+ signalling in cochlear inner hair cells. Eur. J. Neurosci. 21 (2005) 2912-2922
176. 2+ signaling in outer hair cells of the guinea pig cochlea. Brain Res. 1081 (2006) 101-112
177. 2+ entry through presynaptic P2X receptors elicits postsynaptic firing in the brainstem autonomic network. J. Neurosci. 24 (2004) 3125-3135
178. Sperlagh B., Vizi E.S., Wirkner K., and Illes P. P2X7 receptors in the nervous system. Prog. Neurobiol. 78 (2006) 327-346
179. Stamler J.S., Toone E.J., Lipton S.A., and Sucher N.J. (S)NO signals: translocation, regulation, and a consensus motif. Neuron 18 (1997) 691-696
180. Stamler J.S., Lamas S., and Fang F.C. Nitrosylation, the prototypic redox-based signaling mechanism. Cell 106 (2001) 675-683
181. Sudano I., Spieker L.E., Hermann F., Flammer A., Corti R., Noll G., and Luscher T.F. Protection of endothelial function: targets for nutritional and pharmacological interventions. J. Cardiovasc. Pharmacol. 47 Suppl. 2 (2006) S136-S150
182. Thippeswamy T., McKay J.S., Quinn J.P., and Morris R. Nitric oxide, a biological double-faced janus-is this good or bad?. Histol. Histopathol. 21 (2006) 445-458
183. Toda N., and Herman A.G. Gastrointestinal function regulation by nitrergic efferent nerves. Pharmacol. Rev. 57 (2005) 315-338
184. Torres G.E., Egan T.M., and Voigt M.M. Hetero-oligomeric assembly of P2X receptor subunits specificities exist with regard to possible partners. J. Biol. Chem. 274 (1999) 6653-6659
185. Troy C.M., Stefanis L., Greene L.A., and Shelanski M.L. Mechanisms of neuronal degeneration: a final common pathway?. Adv. Neurol. 72 (1997) 103-111
186. Tsuda M., Shigemoto-Mogami Y., Koizumi S., Mizokoshi A., Kohsaka S., Salter M.W., and Inoue K. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424 (2003) 778-783
187. Tsuzuki K., Kondo E., Fukuoka T., Yi D., Tsujino H., Sakagami M., and Noguchi K. Differential regulation of P2X(3) mRNA expression by peripheral nerve injury in intact and injured neurons in the rat sensory ganglia. Pain 91 (2001) 351-360
188. Undi S., Benko R., Wolf M., Illenyi L., Horvath O.P., Antal A., Csontos Z., Vereczkei A., and Bartho L. Purinergic nerves mediate the non-nitrergic relaxation of the human ileum in response to electrical field stimulation. Brain Res. Bull. 71 (2006) 242-244
189. Van Crombruggen K., and Lefebvre R.A. Nitrergic-purinergic interactions in rat distal colon motility. Neurogastroenterol. Motil. 16 (2004) 81-98
190. Vannucchi M.G., Bizzoco E., Corsani L., Gianfriddo M., Pedata F., and Faussone-Pellegrini M.S. Relationships between neurons expressing neuronal nitric oxide synthase, degree of microglia activation and animal survival. A study in the rat cortex after transient ischemia. Brain Res. 1132 (2007) 218-227
191. Vaughn M.W., Kuo L., and Liao J.C. Effective diffusion distance of nitric oxide in the microcirculation. Am. J. Physiol. 274 (1998) H1705-H1714
192. Vaughn M.W., Kuo L., and Liao J.C. Estimation of nitric oxide production and reaction rates in tissue by use of a mathematical model. Am. J. Physiol. 274 (1998) H2163-H2176
193. Vial C., and Evans R.J. Disruption of lipid rafts inhibits P2X1 receptor-mediated currents and arterial vasoconstriction. J. Biol. Chem. 280 (2005) 30705-30711
194. Vial C., Roberts J.A., and Evans R.J. Molecular properties of ATP-gated P2X receptor ion channels. Trends Pharmacol. Sci. 25 (2004) 487-493
195. Viscomi M.T., Florenzano F., Conversi D., Bernardi G., and Molinari M. Axotomy dependent purinergic and nitrergic co-expression. Neuroscience 123 (2004) 393-404
196. Viscomi M.T., Florenzano F., Amadio S., Bernardi G., and Molinari M. Partial resistance of ataxin-2-containing olivary and pontine neurons to axotomy-induced degeneration. Brain Res. Bull. 66 (2005) 212-221
197. Volonté C., Ciotti M.T., D'Ambrosi N., Lockhart B., and Spedding M. Neuroprotective effects of modulators of P2 receptors in primary culture of CNS neurones. Neuropharmacology 38 (1999) 1335-1342
198. Volonté C., Amadio S., Cavaliere F., D'Ambrosi N., Vacca F., and Bernardi G. Extracellular ATP and neurodegeneration. Curr. Drug Targets CNS Neurol. Disord. 2 (2003) 403-412
199. Volonté C., Amadio S., D'Ambrosi N., Colpi M., and Burnstock G. P2 receptor web: complexity and fine-tuning. Pharmacol. Ther. 112 (2006) 264-280
200. von K., and Wetter I.A. Molecular pharmacology of P2Y-receptors. Naunyn Schmiedebergs Arch. Pharmacol. 362 (2000) 310-323
201. Wang X., Arcuino G., Takano T., Lin J., Peng W.G., Wan P., Li P., Xu Q., Liu Q.S., Goldman S.A., and Nedergaard M. P2X7 receptor inhibition improves recovery after spinal cord injury. Nat. Med. 10 (2004) 821-827
202. Waxman S.G. Nitric oxide and the axonal death cascade. Ann. Neurol. 53 (2003) 150-153
203. Whittle B.J. Gastrointestinal effects of nonsteroidal anti-inflammatory drugs. Fundam. Clin. Pharmacol. 17 (2003) 301-313
204. Whittle B.J. Cyclooxygenase and nitric oxide systems in the gut as therapeutic targets for safer anti-inflammatory drugs. Curr. Opin. Pharmacol. 4 (2004) 538-545
205. Whittle B.J. Nitric oxide-modulating agents for gastrointestinal disorders. Expert Opin. Investig. Drugs 14 (2005) 1347-1358
206. Wirkner K., Koles L., Thummler S., Luthardt J., Poelchen W., Franke H., Furst S., and Illes P. Interaction between P2Y and NMDA receptors in layer V pyramidal neurons of the rat prefrontal cortex. Neuropharmacology 42 (2002) 476-488
207. Wirkner K., Kofalvi A., Fischer W., Gunther A., Franke H., Groger-Arndt H., Norenberg W., Madarasz E., Vizi E.S., Schneider D., Sperlagh B., and Illes P. Supersensitivity of P2X receptors in cerebrocortical cell cultures after in vitro ischemia. J. Neurochem. 95 (2005) 1421-1437
208. Wolf G. Nitric oxide and nitric oxide synthase: biology, pathology, localization. Histol. Histopathol. 12 (1997) 251-261
209. Wong P.T., Ruan R.S., Leong S.K., and Yeoh K.H. Compression of the facial nerve caused increased nitric oxide synthase activity in the facial motor nucleus. Neuroscience 67 (1995) 697-702
210. Xiang Z., Bo X., Oglesby I., Ford A., and Burnstock G. Localization of ATP-gated P2X2 receptor immunoreactivity in the rat hypothalamus. Brain Res. 813 (1998) 390-397
211. Xiang Z., He C., and Burnstock G. P2X5 receptors are expressed on neurons containing arginine vasopressin and nitric oxide synthase in the rat hypothalamus. Brain Res. 1099 (2006) 56-63
212. Xu J., Chalimoniuk M., Shu Y., Simonyi A., Sun A.Y., Gonzalez F.A., Weisman G.A., Wood W.G., and Sun G.Y. Prostaglandin E2 production in astrocytes: regulation by cytokines, extracellular ATP, and oxidative agents. Prostaglandins Leukot. Essent. Fatty Acids 69 (2003) 437-448
213. Yakovlev A.G., and Faden A.I. Mechanisms of neural cell death: implications for development of neuroprotective treatment strategies. NeuroRx 1 (2004) 5-16
214. Yamamoto K., Sokabe T., Matsumoto T., Yoshimura K., Shibata M., Ohura N., Fukuda T., Sato T., Sekine K., Kato S., Isshiki M., Fujita T., Kobayashi M., Kawamura K., Masuda H., Kamiya A., and Ando J. Impaired flow-dependent control of vascular tone and remodeling in P2X4-deficient mice. Nat. Med. 12 (2006) 133-137
215. Yao S.T., Gourine A.V., Spyer K.M., Barden J.A., and Lawrence A.J. Localisation of P2X2 receptor subunit immunoreactivity on nitric oxide synthase expressing neurones in the brain stem and hypothalamus of the rat: a fluorescence immunohistochemical study. Neuroscience 121 (2003) 411-419
216. 2+ mobilization and nitric oxide production in cochlear spiral ganglion neurons. Neuroscience 130 (2005) 485-496
217. Zhang J., and Snyder S.H. Nitric oxide in the nervous system. Annu. Rev. Pharmacol. Toxicol. 35 (1995) 213-233
218. Zimmermann H. Ectonucleotidases in the nervous system. Novartis Found. Symp. 276 (2006) 113-128
219. Zipp F., and Aktas O. The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases. Trends Neurosci. 29 (2006) 518-527
220. Zochodne D.W., and Levy D. Nitric oxide in damage, disease and repair of the peripheral nervous system. Cell. Mol. Biol. (Noisy-le-grand) 51 (2005) 255-267